Lung cancer drug is 55% effective in patients
⚡ Quick Summary
Study of the drug Lorbena shows an 81% reduction in the risk of disease progression or death in a 7-year analysis
Study of the drug Lorbena shows an 81% reduction in the risk of disease progression or death in a 7-year analysis